ARTICLE | Emerging Company Profile
Osler targets lab quality Dx for point-of-care access
Oxford diagnostics play raises $85M series C to get first regulatory submission
November 7, 2022 10:34 PM UTC
Osler’s most recent raise should propel the company through its first regulatory submissions in the U.S. and Europe, with the aim of providing central lab quality diagnostic testing in a portable point-of-care device.
Osler Diagnostics Ltd. raised $85 million in a series C round led by an undisclosed strategic investor. The round, announced Monday, brings Osler’s total money raised to at least $167 million...